| Taryn Reitman, | |
|
4258 Via Mira Monte, Agoura Hills, CA 91301-5134 | |
| (818) 309-3420 | |
| Not Available |
| Full Name | Taryn Reitman |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 4258 Via Mira Monte, Agoura Hills, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013400670 | NPI | - | NPPES |
| 29712 | Other | CA | SPEECH-LANGUAGE PATHOLOGY, AUDIOLOGY AND HEARING AID DISPENSERS BOARD |
| 12432 | Other | CA | DEPARTMENT OF CONSUMER AFFAIRS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 12432 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Taryn Reitman, 4258 Via Mira Monte, Agoura Hills, CA 91301-5134 Ph: (818) 309-3420 | Taryn Reitman, 4258 Via Mira Monte, Agoura Hills, CA 91301-5134 Ph: (818) 309-3420 |
News Archive
A new study published today in The American Journal of Human Genetics has identified 44 genes linked to age-related hearing loss giving a much clearer understanding of how the condition develops and potential treatments.
Six genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's according to Mayo Clinic research published in the June 19 edition of the JAMA.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced results of operations for the second quarter of 2011.
Today, BioMed Central announced a fund to help researchers in developing countries attend the conference, Parasite to Prevention. The conference, held in conjunction with Malaria Journal, takes place in Edinburgh UK, 20-22 October 2010.
Teva Pharmaceutical Industries Ltd. today announced new data from the five-year extension of the PreCISe study demonstrating that earlier initiation of treatment with Copaxone (glatiramer acetate injection) in patients presenting with first signs of multiple sclerosis (MS), provided greater effects in delaying conversion to clinically definite MS (CDMS) compared to later treatment initiation after diagnosis of CDMS or after three years on the study.
› Verified 5 days ago
Denise Zweig, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5627 Kanan Rd Ste 184, Agoura Hills, CA 91301 Phone: 805-262-7809 | |
Tina Valcarenghi, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5236 Colodny Dr, Suite #205, Agoura Hills, CA 91301 Phone: 818-865-8135 | |
Amy Simon-weiner, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5520 Fairgrange Dr, Agoura Hills, CA 91301 Phone: 818-991-4314 | |
Siri Ilene Woods, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 29120 Quail Run Dr, Agoura Hills, CA 91301 Phone: 818-631-8410 | |
Chris Byers, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5012 Chesebro Rd, Suite 101, Agoura Hills, CA 91301 Phone: 818-419-1123 | |
Vicki Claymon, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6314 Kerryhill Ct, Agoura Hills, CA 91301 Phone: 818-268-7693 |